Corteva, Inc. $CTVA Shares Acquired by S.E.E.D. Planning Group LLC

S.E.E.D. Planning Group LLC increased its position in shares of Corteva, Inc. (NYSE:CTVA) by 6.9% during the fourth quarter, Holdings Channel reports. The institutional investor owned 185,508 shares of the company’s stock after buying an additional 11,938 shares during the quarter. Corteva comprises about 3.5% of S.E.E.D. Planning Group LLC’s portfolio, making the stock its 10th largest holding. S.E.E.D. Planning Group LLC’s holdings in Corteva were worth $12,435,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Wealth Enhancement Advisory Services LLC lifted its stake in Corteva by 13.6% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 172,072 shares of the company’s stock worth $12,154,000 after acquiring an additional 20,572 shares during the last quarter. NorthCrest Asset Manangement LLC increased its position in shares of Corteva by 3.9% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 143,051 shares of the company’s stock valued at $9,706,000 after purchasing an additional 5,315 shares during the last quarter. Grove Bank & Trust increased its position in shares of Corteva by 31.6% in the 4th quarter. Grove Bank & Trust now owns 1,136 shares of the company’s stock valued at $76,000 after purchasing an additional 273 shares during the last quarter. Harbor Investment Advisory LLC raised its holdings in shares of Corteva by 81.6% in the 4th quarter. Harbor Investment Advisory LLC now owns 2,030 shares of the company’s stock valued at $136,000 after purchasing an additional 912 shares in the last quarter. Finally, CWA Asset Management Group LLC lifted its position in shares of Corteva by 4.1% during the 4th quarter. CWA Asset Management Group LLC now owns 19,136 shares of the company’s stock worth $1,283,000 after purchasing an additional 751 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Trading Up 0.7%

NYSE CTVA opened at $77.86 on Tuesday. The firm’s fifty day moving average price is $75.28 and its 200 day moving average price is $69.38. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The company has a market capitalization of $52.27 billion, a price-to-earnings ratio of 49.28, a price-to-earnings-growth ratio of 2.64 and a beta of 0.72.

Corteva (NYSE:CTVA) last announced its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same period in the previous year, the company earned $0.32 earnings per share. Corteva’s quarterly revenue was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were issued a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s payout ratio is presently 45.57%.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.15% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently commented on CTVA shares. Oppenheimer set a $86.00 target price on shares of Corteva in a research note on Thursday, February 5th. Bank of America raised their price target on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research note on Thursday, January 8th. Argus raised Corteva to a “strong-buy” rating in a report on Friday, January 16th. Royal Bank Of Canada upped their price objective on Corteva from $80.00 to $89.00 and gave the stock an “outperform” rating in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. downgraded Corteva from an “overweight” rating to a “neutral” rating and increased their price objective for the company from $75.00 to $77.00 in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.